Trial intelligence / Profile preview

PBSC vs Bone Marrow for CML

NCT00002789Phase 3Completed

Sponsor
Fred Hutchinson Cancer Center
Start
May 1996
Primary completion
Sep 2001
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of peripheral blood stem cells in chronic myeloid leukemia (CML), sponsored by Fred Hutchinson Cancer Center. Started May 1996; status: completed.

02

Drugs

peripheral blood stem cells
03

Conditions

chronic myeloid leukemia (CML)

Beyond the preview

Go deeper on NCT00002789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call